The study, led by NYU researchers, provides a mathematical framework to find gene sets identifiable via both methods, revealing tissue architecture.
The deal gives Definitive Healthcare a foothold in the genomics market as it looks to build its own genomic data pipeline to serve through PatientFinder's CohortBuilder tool.
The multistate rural health system will adopt Color technology to move to NGS and enhance online engagement for its Imagenetics clinical genomics program.
As part of the deal, Ionis also took a $10 million equity stake in Empirico and was the lead investor in the company's Series A-2 financing round.
The deal follows a number of recent acquisitions in the animal genomics space for Neogen including Canadian animal genomics firm Delta Genomics Centre.
As 2020 dawns, forensic genomics is poised for growth as companies aim to harness the power of consumer databases coupled with advances in sequencing.
The investigators used gene expression, chromatin interaction, and functional annotations to prioritize 191 genes as targets of potentially causal variants.
Mayo Clinic Ventures and NTT Venture Capital have invested in the AI software developer to synthesize biomedical data for drug development and precision medicine.
The University of Washington spinout will use the funding to commercialize duplex sequencing technology to detect low-frequency DNA mutations.
Fresh off its first major fundraise, the startup DTC biobanking company is preparing to launch a new service under the GoodCell Diagnostics brand name.
The fledgling company, started as a promise to the founder's dying sister, is trying to succeed in a consumer niche where so many others have failed.
The two companies had worked closely together since Parabricks spun out of the University of Michigan in 2015 and entered the Nvidia accelerator program.
The exclusive distribution deal expands the Finnish bioinformatics software company's footprint in the Middle East, Africa, and Asia.
Using the free service, called Fingenious, researchers will be able to access genomic data generated by the country's FinnGen project, which aims to genotype 500,000 Finns by 2023.
Computational hardware maker Nvidia has purchased Parabricks, which has applied GPU technology to bring whole-genome sequencing processing time under an hour.
In addition to developing standards for proteomics, metabolomics, and other kinds of data, DNAnexus will develop tools to help reviewers quickly and easily assess analysis pipelines.
IQvia, the lead investor in this round, will work with BC Platforms to integrate genomic and clinical data in a secure environment to support biomedical research.
The company will use the funding to market its GoodCell Diagnostics service, which combines genetic testing and personally controlled biobanking.
Included in the deal is Diagnomics' minority stake in the Eone-Diagnomics Genome Center, a Korean provider of clinical and consumer genetics products and services.
The group is mailing pharmacogenetic information back to patients, with plans to deliver genetic disease risk and carrier screening results.
The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.
A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.
The Los Angeles Times reports that only a third of California students meet the state's new science standards.
In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.